21 July 2022 - Enfortumab vedotin is an antibody-drug conjugate targeting nectin-4, an adhesion protein located on the surface of epithelial ...
19 July 2022 - The TGA has provisionally approved a paediatric dose of the Moderna COVID-19 vaccine, Spikevax, for use ...
15 July 2022 - Xembify is yet another presentation of human immunoglobulin. ...
6 July 2022 - On 5 July 2022, the TGA granted two provisional determinations to Pfizer in relation to COVID-19 ...
30 June 2022 - On 28 June 2022, the TGA granted a provisional determination to Pfizer Australia in relation to ...
15 June 2022 - Tebentafusp is a bi-specific fusion protein. ...
13 June 2022 - In Australia, Nuvaxovid is the first protein-based COVID-19 vaccine registered for use as a booster regardless ...
8 June 2022 - Kimmtrak demonstrated statistically and clinically meaningful overall survival benefit, hazard ratio of 0.51, with median overall survival ...
26 May 2022 - Osilodrostat phosphate is a cortisol synthesis inhibitor. ...
6 May 2022 - On 7 April 2022, the TGA announced receipt of an application from GSK for a higher (1000 ...
28 April 2022 - On 27 April 2022, the TGA granted a provisional determination to Moderna in relation to its ...
19 April 2022 - iHealthScreen is the first company in the USA to receive a CE certification, Australian Health approval, and ...
13 April 2022 - Sotorasib is a Kirsten rat sarcoma (KRAS) G12C inhibitor, which covalently and irreversibly binds to the unique ...
12 April 2022 - Anifrolumab is a human immunoglobulin G1 kappa monoclonal antibody that binds to subunit 1 of the type ...
8 April 2022 - The TGA has approved yet another adalimumab biosimilar. ...